SMTL ID : 4xg7.1

Crystal structure of an inhibitor-bound Syk

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

monomer

Ligands

1 x X7G: 1-[(3-methyl-1-{2-[(1-methyl-1H-indazol-5-yl)amino]pyrimidin-4-yl}-1H-pyrazol-4-yl)methyl]azetidin-3-ol(Non-covalent)

X7G.1: 14 residues within 4Å: Chain A: L.22, V.30, A.45, M.93, E.94, M.95, A.96, E.97, G.99, P.100, R.143, N.144, L.146, D.157 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.22, A:V.30, A:A.45, A:L.146 Hydrogen bonds: A:A.96, A:A.96, A:R.143 Salt bridges: A:D.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, S.J. et al., Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs. Febs J. (2016)

Release Date

2015-12-30

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence